Skip to main content
PMC home page
Cancer Immunology, Immunotherapy : CII logoLink to Cancer Immunology, Immunotherapy : CII
. 1983 Mar;14(3):196–201. doi: 10.1007/BF00205360

Immunochemical characterization of a human high molecular weight — melanoma associated antigen identified with monoclonal antibodies

Barry S Wilson 1, Giovanna Ruberto 2, Soldano Ferrone 1,2,✉
PMCID: PMC11039124  PMID: 6188530

Abstract

Sodium dodecyl sulfate polyacrylamide gel analysis of a high molecular weight (HMW) human melanoma associated antigen (MAA) defined by murine monoclonal antibodies revealed a number of distinct polypeptides ranging from 80,000 up to 280,000 daltons, in addition to an extremely heterogeneous group of components distributed over a wide range in apparent molecular weight (300,000–700,000 daltons). The 280,000 dalton and the larger heterogeneous molecular weight material are glycosylated since they are labeled with 3H-sugars. The HMW-MAA is readily solubilized in the absence of detergents and the entire series of polypeptides fractionates together in the void volume of a Sephadex G200 column. Peptide maps of the various polypeptides of the HMW-MAA, generated by Staphylococcus aureus V-8 protease, are essentially the same except that some of the proteolytic fragments derived from the lower molecular weight polypeptides (80,000 daltons) are present in greater amounts than are similar fragments derived from the larger molecular weight polypeptides; the latter finding suggests that the complexity in molecular weight of the MAA may reflect combinations of several base subunits. Proteolytic cleavage of the HMW-MAA generates a number of peptides ranging in molecular weight from 77,000 daltons to less than 12,000 daltons, which still react with monoclonal antibodies and can distinguish monoclonal antibodies specific for different antigenic determinants of this MAA.

Keywords: Sodium Dodecyl Sulfate, Apparent Molecular Weight, Antigenic Determinant, Large Molecular Weight, G200 Column

References

  • 1.Allison JP, Belvedere M, Reisfeld RA, Pellegrino MA, Ferrone S. Serological and immunochemical characterization of HLA-A9 xenoantisera. J Immunol. 1978;121:579–585. [PubMed] [Google Scholar]
  • 2.Bordier C, Crettol-Harviner A. Peptide mapping of heterogeneous protein samples. J Biol Chem. 1979;254:2565–2567. [PubMed] [Google Scholar]
  • 3.Bumol TF, Reisfeld RA. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc Natl Acad Sci USA. 1982;79:1245–1249. doi: 10.1073/pnas.79.4.1245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Carrel S, Accolla RS, Carmagnola AL, Mach JP. Common melanoma-associated antigen(s) detected by monoclonal antibodies. Cancer Res. 1980;40:2523–2528. [PubMed] [Google Scholar]
  • 5.Cleveland DW, Fischer SG, Kirschner MW, Laemmli UK. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977;252:1102–1106. [PubMed] [Google Scholar]
  • 6.Cuatrecasas P. Protein purification by affinity chromatography. Derivativations of agarose and polyacrylamide beads. J Biol Chem. 1970;245:3059–3065. [PubMed] [Google Scholar]
  • 7.Dippold WG, Lloyd KO, Li LTL, Ikeda H, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma; definition of six antigenic systems with mouse monoclonal antibodies. Proc Natl Acad Sci USA. 1970;77:6114–6118. doi: 10.1073/pnas.77.10.6114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Ferrone S, Pellegrino MA. Antigens and antibodies in malignant melanoma. In: Waters H, editor. Handbook of cancer immunology. New York: Garland Press; 1978. p. 291. [Google Scholar]
  • 9.Hellstrom I, Hellstrom KE, Yeh M. Lymphocyte-dependent antibodies to antigens 3.1, a cell-surface antigen expressed by a subgroup of human melanomas. Int J Cancer. 1981;27:281–285. doi: 10.1002/ijc.2910270305. [DOI] [PubMed] [Google Scholar]
  • 10.Herlyn M, Clark WH, Mastrangelo MJ, Guerry ND, Elder DW, La Rossa D, Hamilton R, Bondi E, Tuthill R, Steplewski Z, Koprowski H. Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. Cancer Res. 1980;40:3602–3609. [PubMed] [Google Scholar]
  • 11.Imai K, Ng AK, Ferrone S. Characterization of monoclonal antibodies to human melanoma-associated antigens. J Natl Cancer Inst. 1981;66:489–496. [PubMed] [Google Scholar]
  • 12.Imai K, Natali PG, Kay NE, Wilson BS, Ferrone S. Tissue distribution and molecular profile of a differentiation antigen detected by a monoclonal antibody (345.134S) produced against human melanoma cells. Cancer Immunol Immunother. 1982;12:159–166. [Google Scholar]
  • 13.Imai K, Wilson BS, Ruberto G, Nakanishi T, Yachi A, Ferrone S. Molecular heterogeneity of a high-molecular-weight human melanoma-associated antigen (MAA) detected by monoclonal antibodies. In: Peters H, editor. Protides of the biological fluids. Oxford: Pergamon Press; 1982. pp. 893–897. [Google Scholar]
  • 14.Johnson JP, Demmer-Dieckmann M, Meo T, Haden MR, Reithmuller G. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin. Eur J Immunol. 1981;11:825–831. doi: 10.1002/eji.1830111015. [DOI] [PubMed] [Google Scholar]
  • 15.Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:258–495. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  • 16.Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature. 1970;222:680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  • 17.Liao SK, Clarke BJ, Kwong PC, Brickerden A, Gallie B, Dent PB. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells. Eur J Immunol. 1981;11:450–454. doi: 10.1002/eji.1830110603. [DOI] [PubMed] [Google Scholar]
  • 18.Loop SM, Nishiyama K, Hellstrom I, Woodbury RG, Brown JP, Hellstrom KE. Two human tumor-associated antigens p 155 and p 210 detected by monoclonal antibodies. Int J Cancer. 1981;27:775–781. doi: 10.1002/ijc.2910270608. [DOI] [PubMed] [Google Scholar]
  • 19.Natali PG, Imai K, Wilson BS, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S. Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells. J Natl Cancer Inst. 1981;67:591–601. [PubMed] [Google Scholar]
  • 20.Reiser J, Wardale J. Immunological detection of specific proteins in total cell extracts by fractionation in gels and transfer to diazophenylthioether paper. Eur J Biochem. 1981;114:569–575. doi: 10.1111/j.1432-1033.1981.tb05182.x. [DOI] [PubMed] [Google Scholar]
  • 21.Salisbury JG, Graham JM. Cell surface radioiodination with the sparingly soluble catalyst Iodogen. Differences between dividing and nondividing thymocytes. Biochem J. 1981;194:351–355. doi: 10.1042/bj1940351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Segrest JP, Jackson RL, Andrews EP, Marchesi VT. Human erythrocyte membrane glycoproteins: A re-evaluation of the molecular weight as determined by SDS polyacrylamide gel electrophoresis. Biochem Biophys Res Commun. 1971;44:390–395. doi: 10.1016/0006-291x(71)90612-7. [DOI] [PubMed] [Google Scholar]
  • 23.Werkmeister J, Edwards A, McCarthy W, Hersey P. Prognostic significance of expression of antigens on melanoma cells. Cancer Immunol Immunother. 1980;9:233–240. [Google Scholar]
  • 24.Wilson BS, Ruberto G, Ferrone S. Sulfation and molecular weight of fibronectin shed by human melanoma cells. Biochem Biophys Res Commun. 1981;101:1047–1051. doi: 10.1016/0006-291x(81)91854-4. [DOI] [PubMed] [Google Scholar]
  • 25.Wilson BS, Imai K, Natali PG, Bigotti A, Cavaliere R, Pellegrino MA, Ferrone S. Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. Int J Cancer. 1981;28:293–300. doi: 10.1002/ijc.2910280307. [DOI] [PubMed] [Google Scholar]
  • 26.Wilson BS, Imai K, Natali PG, Cavaliere R, Pellegrino MA, Ferrone S. Antigenic profile of human melanoma cells: Analysis with monoclonal antibodies. In: Reisfeld RA, Ferrone S, editors. Melanoma antigens and antibodies. New York: Plenum Press; 1982. pp. 401–433. [Google Scholar]
  • 27.Wilson BS, Giacomini P, Imai K, Natali PG, Nakanishi T, Ruberto G, Ferrone S (1982b) Human melanoma associated antigens identified with monoclonal antibodies: Structural profile and potential usefulness in immunodiagnosis and immunotherapy. Ric Clin Lab (in press) [DOI] [PubMed]
  • 28.Woodbury RG, Brown JF, Yeh MY, Hellstrom I, Hellstrom KW. Identification of a cell surface protein p97 in human melanoma and certain other neoplasms. Proc Natl Acad Sci USA. 1980;77:2183–2187. doi: 10.1073/pnas.77.4.2183. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancer Immunology, Immunotherapy : CII are provided here courtesy of Springer

RESOURCES